4/A: USPH Director Corrects Stock Grant Filing

Sentiment:

Amendment to Statement of Changes in Beneficial Ownership


Director Kathleen A. Gilmartin filed an amendment to correct the reported transaction price of a restricted stock grant.

Summary

  • Director Kathleen A. Gilmartin amended a previously filed Form 4 regarding a grant of 2,306 shares of common stock.
  • The amendment corrects the transaction price from $61.61 to $0.00, reflecting the nature of the restricted stock grant.
  • The total beneficial ownership following the transaction is 27,092 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative event with no impact on the company's financial health or strategic direction.

Positives

  • Transparency in correcting administrative reporting errors regarding equity compensation.

Negatives

  • Administrative error in the original filing required a corrective amendment.

Risks

  • None identified; this is a routine administrative correction.

Future Outlook

The filing does not provide forward-looking financial guidance, focusing solely on the correction of an insider transaction record.

Management Comments

  • The transaction price should have been reported as $0.00, not $61.61.

Industry Context

StockSavvy.ai notes that administrative amendments to SEC filings are common and generally do not reflect underlying operational or financial shifts within the healthcare services sector.

Comparison to Industry Standards

  • The use of restricted stock units for director compensation is standard practice among mid-cap healthcare companies.
  • The correction of clerical errors in Section 16 filings is a standard compliance procedure.

Stakeholder Impact

  • Minimal impact on shareholders as this is a routine correction of an insider filing.

Next Steps

  • Lapsing of restrictions on 1,153 shares on August 20, 2026.
  • Lapsing of restrictions on 576 shares on November 20, 2026.
  • Lapsing of restrictions on 577 shares on March 6, 2027.

Key Dates

DateDescription
05/19/2026Date of the original restricted stock grant transaction.
05/20/2026Date of the original Form 4 filing.
05/28/2026Date of the Form 4/A amendment filing.
08/20/2026First tranche of restricted stock restrictions lapse.
11/20/2026Second tranche of restricted stock restrictions lapse.
03/06/2027Final tranche of restricted stock restrictions lapse.

Keywords

USPH, U.S. Physical Therapy, Form 4/A, Insider Trading, Director Compensation, Equity Incentive Plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.